Knockdown of CKAP4 inhibited cell proliferation and suppressed Akt activity in vitro in PDAC and ESCC [7,8,9,10], while it also impeded tumor formation in vivo [8,9]. Here, CKAP4 is linked to esophageal squamous cell carcinoma.